Clinical application of chromosomal microarray analysis in fetuses with increased nuchal translucency and normal karyotype

被引:28
|
作者
Su, Linjuan [1 ]
Huang, Hailong [1 ]
An, Gang [1 ]
Cai, Meiying [1 ]
Wu, Xiaoqing [1 ]
Li, Ying [1 ]
Xie, Xiaorui [1 ]
Lin, Yuan [1 ]
Wang, Meiying [1 ]
Xu, Liangpu [1 ]
机构
[1] Fujian Med Univ, Fujian Prov Matern & Childrens Hosp, Fujian Prov Key Lab Prenatal Diag & Birth Defect, Affiliated Hosp, Fuzhou, Fujian, Peoples R China
来源
关键词
chromosomal microarray analysis; karyotyping; nuchal translucency; prenatal diagnosis; GENOMIC MICROARRAY; THICKNESS; MOSAICISM; DELETIONS; 22Q11.2;
D O I
10.1002/mgg3.811
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background Submicroscopic chromosomal imbalance is associated with an increased nuchal translucency (NT). Most previous research has recommended the use of chromosomal microarray analysis (CMA) for prenatal diagnosis if the NT >= 3.5 mm. However, there is no current global consensus on the cutoff value for CMA. In this study, we aimed to discuss the fetuses with smaller increased NT which was between cutoff value of NT for karyotype analysis (NT of 2.5 mm in China) and the recommended cutoff value for CMA (NT of 3.5 mm) whether should be excluded from CMA test. Methods Singleton pregnant women (N = 192) who had undergone invasive procedures owing to an increased NT (NT >= 2.5 mm) were enrolled. Fetal cells were collected and subjected to single nucleotide polymorphism array and karyotype analyses simultaneously. Cases were excluded if the karyotype analysis indicated aneuploidy and apparent structural aberrations. Results Fourteen cases of aneuploidy and four cases of structural abnormalities were excluded. Of the remaining 174 cases, 119 fetuses had NTs of 2.5-3.4 mm, and 55 fetuses with NT >= 3.5 mm. Eleven copy number variants (CNVs) were identified. In fetuses with smaller NTs, six (6/119, 5.9%) variations were detected, including two (2/119, 1.6%) clinically significant CNVs (pathogenic or likely pathogenic CNV), one likely benign CNV, two variants unknown significance, and one incidental CNV. Five (5/55, 9.1%) variations were found in fetuses with NT >= 3.5 mm. Among these CNVs, three (3/55, 5.5%) cases had clinically significant CNVs, and two had likely benign CNV. There were no statistically significant differences in the incidence of all CNVs and clinically significant CNVs in the two groups (p > 0.05). Conclusion CMA improved the diagnostic yield of chromosomal aberrations for fetuses with NTs of 2.5-3.4 mm and apparently normal karyotype, regardless of whether other ultrasonic abnormalities were observed.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Chromosomal Microarray Analysis for the Fetuses with Aortic Arch Abnormalities and Normal Karyotype
    Wu, Xiaoqing
    Li, Ying
    Su, Linjuan
    Xie, Xiaorui
    Cal, Meiying
    Lin, Na
    Huang, Hailong
    Lin, Yuan
    Xu, Liangpu
    [J]. MOLECULAR DIAGNOSIS & THERAPY, 2020, 24 (05) : 611 - 619
  • [42] Nuchal translucency and major congenital heart defects in fetuses with normal karyotype: a meta-analysis
    Sotiriadis, A.
    Papatheodorou, S.
    Eleftheriades, M.
    Makrydimas, G.
    [J]. ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2013, 42 (04) : 383 - 389
  • [43] Chromosomal Microarray Analysis for the Fetuses with Aortic Arch Abnormalities and Normal Karyotype
    Xiaoqing Wu
    Ying Li
    Linjuan Su
    Xiaorui Xie
    Meiying Cai
    Na Lin
    Hailong Huang
    Yuan Lin
    Liangpu Xu
    [J]. Molecular Diagnosis & Therapy, 2020, 24 : 611 - 619
  • [44] Outcome of fetuses with increased nuchal translucency
    Bilardo, CM
    Müller, MA
    Pajkrt, E
    [J]. CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2001, 13 (02) : 169 - 174
  • [45] Universal Prenatal Chromosomal Microarray Analysis: Additive Value and Clinical Dilemmas in Fetuses with a Normal Karyotype
    Bornstein, Eran
    Berger, Sharon
    Cheung, Sau W.
    Maliszewski, Kristen T.
    Patel, Ankita
    Pursley, Amber N.
    Lenchner, Erez
    Bacino, Carlos
    Beaudet, Arthur L.
    Divon, Michael Y.
    [J]. AMERICAN JOURNAL OF PERINATOLOGY, 2017, 34 (04) : 340 - 348
  • [46] NUCHAL TRANSLUCENCY MEASUREMENT IN NORMAL FETUSES
    PAJKRT, E
    BILARDO, CM
    VANLITH, JMM
    MOL, BWJ
    BLEKER, OP
    [J]. OBSTETRICS AND GYNECOLOGY, 1995, 86 (06): : 994 - 997
  • [47] Ultrasound and echocardiographic findings obtained in the second and third trimesters of gestation in fetuses with normal karyotype and increased nuchal translucency
    Moczulska, Hanna
    Janiak, Katarzyna
    Slodki, Maciej
    Respondek-Liberska, Maria
    [J]. JOURNAL OF ULTRASONOGRAPHY, 2013, 13 (52) : 21 - 30
  • [48] Differential proteomics analysis of amniotic fluid in pregnancies of increased nuchal translucency with normal karyotype
    Cheng, Po-Jen
    Wang, Tzu-Hao
    Huang, Shang-Yu
    Kao, Chuan-Chi
    Lu, Jen-Hao
    Hsiao, Ching-Hwa
    Shaw, S. W. Steven
    [J]. PRENATAL DIAGNOSIS, 2011, 31 (03) : 274 - 281
  • [49] Outcome of fetuses with increased risk of chromosomal anomalies, based on nuchal translucency measurement
    Camano, Luiz
    Moron, Antonio Fernandes
    Nardozza, Luciano Marcondes
    da Silva Pares, David Baptista
    Chinen, Paulo Alexandre
    [J]. REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA, 2005, 27 (03): : 155 - 160
  • [50] Increased nuchal translucency thickness and normal karyotype:: time for parental reassurance
    Bilardo, C. M.
    Muller, M. A.
    Pajkrt, E.
    Clur, S. A.
    Van Zalen, M. M.
    Bijlsma, E. K.
    [J]. ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2007, 30 (01) : 11 - 18